SB
SBIO.LSE Invesco NASDAQ Biotech UCITS ETF
- USD
No recent price
- Total assets
- 276M
- Expense ratio
- 0.42%
- Dividend yield
- -
- 1-year return
- +37.02%
- Holdings
- 1
- Since
- 2014
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does SBIO.LSE invest in?
Tracks Morningstar Gbl Biotechnology NR USD- Mostly US stocks (91.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (91.9%)
- Top 3 holdings: 100.0% of the fund
Asset allocation
- US stocks 91.2%
- Non-US stocks 4.9%
Top holdings
- TRS NASDAQ Biotechnology TR USD 100.00%
Invesco NASDAQ Biotech UCITS ETF performance
Sharpe ratio 0.00- This year
- +27.30%
- 1 year
- +37.02%
- 3 years
- +26.15%
- 5 years
- +8.80%
Volatility 15.3% over 1 year and 16.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
SBIO.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Invesco NASDAQ Biotech UCITS ETF top holdings
100.0% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| TRS NASDAQ Biotechnology TR USD XNBI.US | Other | United States | 100.00% |
SBIO.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
SBIO.LSE regional exposure
- North America91.9%
- Europe Developed2.3%
- United Kingdom1.9%
- Asia Emerging0.1%
- Australasia0.1%
- Africa/Middle East0.0%
- Asia Developed0.0%
Share of the stocks in the fund.
Company size
Average market cap 24.5B- Mega cap0.6%
- Big cap24.6%
- Medium cap35.2%
- Small cap25.4%
- Micro cap11.3%
Invesco NASDAQ Biotech UCITS ETF fund profile
- Fund name
- Invesco NASDAQ Biotech UCITS ETF
- Ticker
- SBIO.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Biotechnology NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Nov 6, 2014
- Trading currency
- USD
- Expense ratio
- 0.42%